inflammation semaglutide GLP-1 drugs calm beyond diabetes and weight loss semaglutide help with inflammation Semaglutide:

However, several drugs, including teprotumumab and BIIB-022, which target IGF-1R, have not shown good therapeutic effects in clinical trials, possibly due to the lack of reliable IGF-1R inhibition biomarkers

You shouldn't suffer in silence

Durability of effectiveness between users of once-weekly semaglutide and dipeptidyl peptidase 4 Inhibitors (DPP-4i) in US Adults with Type 2 Diabetes

Low-impact aerobic options For knee and hip osteoarthritis, the gentlest aerobic options are walking on flat terrain with supportive footwear, swimming or water aerobics (buoyancy reduces joint load), and cycling

AdipoAtlas: a reference lipidome for human white adipose tissue

Between resolved shortages, an FDA proposal to permanently close the compounding pathway, and mounting safety concerns, 2026 has brought the most significant shift in GLP-1 access since these drugs launched